1.The recent evolution of electrical vehicle vs traditional fossil fuel vehicle is taking shape phenomenally. This is reminding me of our Imugene revolutionary science vs other startups basing on traditional chemo/radiology... One year ago, no one could’ve imagined Elon Musk would be invited as the “surprise guest” to speak at the this year Volkswagen Conference recently, could you ?!
2.Foxconn, the world renowned assembly company for iPhones and other Apple devices, has just launched 3 different models of EV, all built in less than one year from conceptualisation using an “open platform “ called Mobility in Harmony (MIH), an alliance/collaboration of various strategic parts suppliers launched by Foxconn.
Imugene’s recent strategic partnership collaboration with Celularity, which has in-house drug-grade GMP manufacturing facility is similar to some extent. Anyway, I’m expecting some nice surprises soon ! Can cancer drug be available at OTC?
3.Basing on the positive Her-Vaxx Ph 2 data announced on 1/9/21, three new combo studies will be conducted; namely NextHERIZON , NeoHERIZON and NeuHERIZON. These will further strengthen our negotiation position as one of these three studies is “Investigator Sponsored “. Discussion on potential partnership/licensing agreement is not anything unusual but I have a gut feeling quite a decent one is in negotiations” AIMHO.
As usual time will tell.
Patience will be rewarded as long as Leslie and her team continues delivering good science
Glta+ needy patientsdyor
ps. Current TA seems to be pointing an uptrend pattern too. Today’s closing @45c is above the short and medium term moving average golden crossing of 43.3c.
Looking nice to me anyway.
- Forums
- ASX - By Stock
- Rubbing my ball
1.The recent evolution of electrical vehicle vs traditional...
-
- There are more pages in this discussion • 798 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $418.9M |
Open | High | Low | Value | Volume |
6.0¢ | 6.2¢ | 5.6¢ | $1.863M | 31.44M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 214965 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 214965 | 0.057 |
14 | 1550875 | 0.056 |
26 | 4138021 | 0.055 |
9 | 1730287 | 0.054 |
4 | 131036 | 0.053 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 60000 | 1 |
0.059 | 708216 | 4 |
0.060 | 1196314 | 8 |
0.061 | 471000 | 3 |
0.062 | 236412 | 6 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online